Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentoxifylline as Anti-Inflammatory in Rheumatoid Arthritis
NCT06998628Phase 2Recruiting
- Sponsor
- Tanta University
- Start
- Jun 2025
- Primary completion
- May 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pentoxifylline in rheumatoid arthritis (RA), sponsored by Tanta University. Started Jun 2025; status: recruiting.
02
Drugs
pentoxifylline
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT06998628.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06998628.